Applied Therapeutics (APLT) PT Raised to $38 at Citi
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Wall St futures mixed as Apple falls on margin warning, midterm results awaited
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts APLT Hot Sheet
Price: $0.10 --0%
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 15 | New: 12
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 15 | New: 12
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on Applied Therapeutics (NASDAQ: APLT) to $38.00 (from $37.00) while maintaining a Buy rating.
You May Also Be Interested In
- Ethos Technologies (LIFE) PT Raised to $61 at Citi
- Vale S.A. (VALE) PT Lowered to $13 at Wells Fargo
- Wealthfront Corporation (WLTh) PT Raised to $12 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
